Danaher Corporation $DHR Holdings Raised by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. increased its stake in Danaher Corporation (NYSE:DHR) by 9.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 334,852 shares of the conglomerate’s stock after purchasing an additional 30,027 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Danaher were worth $66,388,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. WFA of San Diego LLC purchased a new stake in shares of Danaher during the second quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher during the 2nd quarter worth about $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth about $28,000. Tripletail Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter valued at about $31,000. Finally, Heartwood Wealth Advisors LLC bought a new stake in shares of Danaher in the 3rd quarter valued at approximately $37,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on DHR. Morgan Stanley began coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective on the stock. KeyCorp restated an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Robert W. Baird set a $251.00 price objective on shares of Danaher in a research note on Thursday, January 29th. Evercore reiterated an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Finally, Guggenheim raised their target price on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Stock Performance

NYSE:DHR opened at $212.37 on Tuesday. The firm’s 50-day moving average is $228.40 and its 200-day moving average is $215.71. The company has a market cap of $150.01 billion, a price-to-earnings ratio of 42.14, a PEG ratio of 2.87 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the company earned $2.14 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is currently 25.40%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.